ba0004p120 | (1) | ICCBH2015
Crabtree Nicola
, Hogler Wolfgang
, Sahota Jaskiran
, Chapman Dee
, Walford Jacky
, Roper Helen
, Willis Tracy
, Shaw Nicholas
Background: DMD is a progressive neuromuscular disease often treated with oral glucocorticoids (GC) to prolong ambulation and maintain cardiovascular function. However, the osteotoxic GC effects often result in a skeleton prone to fractures. DMD boys presenting with fractures are treated with bisphosphonates (BP) but evidence of beneficial effects is limited. The aim of this work was to review the use of intravenous BPs in a group of severely affected boys with fractures.<...